The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

TLDR

Variable results in positive‑negative schizophrenia research highlight the need for standardized measurement techniques. The study develops and initially standardizes the PANSS for typological and dimensional assessment of schizophrenia. The 30‑item PANSS, derived from two existing rating systems, operationalizes positive and negative symptoms into four scales—positive, negative, their differential, and overall severity—providing a drug‑sensitive, balanced assessment. In 101 patients, the PANSS scales were normally distributed, reliable, and stable; positive and negative scores were inversely correlated after controlling for general psychopathology, indicating distinct constructs, and multiple studies confirmed its validity, predictive power, drug sensitivity, and utility for typological and dimensional assessment.

Abstract

The variable results of positive-negative research with schizophrenics underscore the importance of well-characterized, standardized measurement techniques. We report on the development and initial standardization of the Positive and Negative Syndrome Scale (PANSS) for typological and dimensional assessment. Based on two established psychiatric rating systems, the 30-item PANSS was conceived as an operationalized, drug-sensitive instrument that provides balanced representation of positive and negative symptoms and gauges their relationship to one another and to global psychopathology. It thus constitutes four scales measuring positive and negative syndromes, their differential, and general severity of illness. Study of 101 schizophrenics found the four scales to be normally distributed and supported their reliability and stability. Positive and negative scores were inversely correlated once their common association with general psychopathology was extracted, suggesting that they represent mutually exclusive constructs. Review of five studies involving the PANSS provided evidence of its criterion-related validity with antecedent, genealogical, and concurrent measures, its predictive validity, its drug sensitivity, and its utility for both typological and dimensional assessment.